Document is current
Any future updates will be listed below
-
Authors
Vela-Casasempere, Paloma https://orcid.org/0000-0001-8566-5172
Otero-Varela, Lucía https://orcid.org/0000-0002-4406-6314
Gómez Sabater, Silvia https://orcid.org/0000-0002-2833-565X
Caño Alameda, Rocío https://orcid.org/0000-0002-2803-4347
Campos Fernández, Cristina
Calvo-Gutiérrez, Jerusalén https://orcid.org/0000-0001-6822-5589
Pérez-Vera, Yanira https://orcid.org/0000-0003-4862-3197
Arija, Sara Manrique https://orcid.org/0000-0003-2284-7846
Bustabad, Sagrario https://orcid.org/0000-0002-4204-1236
Manero Ruiz, Javier
Ruiz Montesino, María Dolores https://orcid.org/0000-0002-9080-121X
Ruíz Gutiérrez, Lucía https://orcid.org/0000-0002-8290-2192
Mera Varela, Antonio https://orcid.org/0000-0001-9380-6975
Moreno Ramos, Manuel José https://orcid.org/0000-0003-3800-7382
Sánchez-Alonso, Fernando https://orcid.org/0009-0000-1189-2380
Castrejón, Isabel https://orcid.org/0000-0003-1811-2417
- License Information
-
More Information
Article History
Received: 14 October 2024
Accepted: 5 May 2025
First Online: 14 May 2025
Declarations
:
: The project was approved by the Research Ethics Committee of the Hospital Universitario Clinic Barcelona (approval code FER-ADA-2015–01), while the reference committee is the Research Ethics Committee of the Hospital Universitario de Canarias. Informed consent was obtained from all participants.
: Not applicable.
: PVC received grants or contracts from GSK, Abbvie, Roche, Novartis, Lilly, AstraZeneca, Pfizer; consulting fees from GSK; honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Abbvie, GSK, Lilly; Support for attending meetings and/or travel from Abbvie.YPV received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Abbvie, Amgen; Support for attending meetings and/or travel from Nordic Pharma, Pfizer, Abbvie; Other financial or non-financial interests from GebroPharma.SMA received consulting fees from ABbvie, UCB, Novartis; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from ABBVIE, PFIZER, UCB, JASSEN, NOVARTIS, GSK, LILLY, ASTRA ZENECA; Support for attending meetings and/or travel from ABBVIE, PFIZER, UCB, JASSEN, NOVARTIS, GSK, LILLY, ASTRA ZENECA.IC received consulting fees from UCB, Alfasigma; honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Boehringer, Gebro, Pfizer, UCB, GSK, Lilly, BMS; Support for attending meetings and/or travel from Janssen, UCB, Lilly, AbbVie, Pfizer.The other authors declare that they have no relevant financial or non-financial interests to disclose.
